Genome editing

Man receives human kidney transplant after surviving 271 days with gene-edited pig organ

Andrews was 66, had end-stage kidney disease, no suitable living donor, and a long anticipated wait time for a deceased donor when he underwent surgery in 2025 to receive a kidney from a pig.

Medical team performing surgery
AERIAL VIEW of the Rambam Health Care Campus in Haifa. (Totem Imaging and Animation Ltd.)

Driving innovation at the frontiers of genomic medicine

 wo male bighorn sheep grazing on Wild Horse Island in Montana.

Feds bust Montana man for super-sheep semen scheme

 Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor.

One child's unexplained symptoms uncovered the origin of rare blood disease - study


How did Europe's first farmers survive disease? New study uncovers answers

Early Neolithic groups from Anatolia spread and settled across Europe in the period from 10,000 to 5,000 years ago and became the first farmers.

 An illustrative depiction of early neolithic farming

Old mice regain eyesight and develop younger brain in new study

The study also cites information theory of aging, which states that "a loss of epigenetic information is a reversible cause of aging." 

 A mouse.

CRISPR gene editing may cause permanent damage - study

Caution from researchers at Tel Aviv University: CRISPR gene editing can damage the genome and might trigger cancer.

 Chromosome segregation In dividing cells. Cell cytoskeleton is depicted in red, DNA is depicted in blue and a protein that marks dividing cells is depicted in green.

TAU researchers test CRISPR genome editing in space

"In the International Space Station, we tested a CRISPR-based detection method developed by Dr. Janice Chen and colleagues in the Doudna lab," TAU's Dr. Dudu Burstein said.

Eytan Stibbe performing the experiment on the International Space Station.

Israeli company reports first ever successful genetically edited cannabis

CanBreed says that using genome editing capabilities, they will be able to develop plants which exhibit improved agronomical traits which would make cannabis farming more affordable and sustainable.

A CanBreed researcher takes a sample from a cannabis plant.

Pluristem joins CRISPR-IL to develop next-gen genome editing products

“We see cell therapy and gene editing as highly synergistic methods to treat and cure diseases using advanced technologies."

Biologists work in a laboratory at Pluristem Theraputics in Haifa